• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transmission of severe acute respiratory syndrome coronavirus 2 through asymptomatic carriers and aerosols: A major public health challenge.无症状携带者和气溶胶传播严重急性呼吸综合征冠状病毒 2:主要的公共卫生挑战。
Rev Soc Bras Med Trop. 2020 Dec 11;53:e20200669. doi: 10.1590/0037-8682-0669-2020. eCollection 2020.
2
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.支持严重急性呼吸综合征冠状病毒 2 在出现症状前或无症状时传播的证据。
Emerg Infect Dis. 2020 Jul;26(7). doi: 10.3201/eid2607.201595. Epub 2020 Jun 21.
3
Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.新型冠状病毒(SARS-CoV-2)在 2019 年冠状病毒病(COVID-19)患者呼吸、说话和唱歌时呼出的呼吸道飞沫中的病毒载量。
Clin Infect Dis. 2022 May 30;74(10):1722-1728. doi: 10.1093/cid/ciab691.
4
Asymptomatic carriage and transmission of SARS-CoV-2: What do we know?无症状的 SARS-CoV-2 携带和传播:我们了解多少?
Can J Anaesth. 2020 Oct;67(10):1424-1430. doi: 10.1007/s12630-020-01729-x. Epub 2020 Jun 2.
5
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.干预措施以减轻 SARS-CoV-2 在新加坡的早期传播:一项建模研究。
Lancet Infect Dis. 2020 Jun;20(6):678-688. doi: 10.1016/S1473-3099(20)30162-6. Epub 2020 Mar 23.
6
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
7
Infection Prevention Precautions for Routine Anesthesia Care During the SARS-CoV-2 Pandemic.SARS-CoV-2 大流行期间常规麻醉护理的感染预防措施。
Anesth Analg. 2020 Nov;131(5):1342-1354. doi: 10.1213/ANE.0000000000005169.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
10
Overview of transnational recommendations for COVID-19 transmission control in dental care settings.跨国建议概述,用于控制牙科环境中的 COVID-19 传播。
Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):655-664. doi: 10.1111/odi.13431. Epub 2020 Jun 3.

引用本文的文献

1
Clinical and Epidemiological Characteristics of Patients with COVID-19 Admitted to the Intensive Care Unit: A Two-Year Retrospective Analysis.入住重症监护病房的COVID-19患者的临床和流行病学特征:一项为期两年的回顾性分析
Life (Basel). 2023 Mar 9;13(3):741. doi: 10.3390/life13030741.
2
Microstructural evaluation and recommendations for face masks in community use to reduce the transmission of respiratory infectious diseases.用于减少呼吸道传染病传播的社区使用口罩的微观结构评估和建议。
Comput Methods Programs Biomed. 2022 Nov;226:107154. doi: 10.1016/j.cmpb.2022.107154. Epub 2022 Sep 24.
3
Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2.用于鉴别检测针对新冠病毒刺突蛋白受体结合域(RBD)和非RBD区域的IgG抗体的多表位蛋白
Vaccines (Basel). 2021 Sep 3;9(9):986. doi: 10.3390/vaccines9090986.
4
Understanding misinformation infodemic during public health emergencies due to large-scale disease outbreaks: a rapid review.在大规模疾病爆发引发的突发公共卫生事件期间理解错误信息疫情:一项快速综述
Z Gesundh Wiss. 2023;31(4):553-573. doi: 10.1007/s10389-021-01565-3. Epub 2021 May 1.

本文引用的文献

1
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis.评估无症状新冠病毒感染的程度及其社区传播潜力:系统评价与荟萃分析。
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):223-234. doi: 10.3138/jammi-2020-0030. eCollection 2020 Dec.
2
SARS-CoV-2 in Environmental Samples of Quarantined Households.新冠病毒在隔离家庭环境样本中的情况。
Viruses. 2022 May 17;14(5):1075. doi: 10.3390/v14051075.
3
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.其他冠状病毒株赋予的针对 SARS-CoV-2 的潜在 CD8+ T 细胞交叉反应性。
Front Immunol. 2020 Nov 5;11:579480. doi: 10.3389/fimmu.2020.579480. eCollection 2020.
4
Variation in microparasite free-living survival and indirect transmission can modulate the intensity of emerging outbreaks.微生物寄生虫自由生活的存活和间接传播的变化可以调节新出现疫情的强度。
Sci Rep. 2020 Nov 27;10(1):20786. doi: 10.1038/s41598-020-77048-4.
5
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
6
Toilets dominate environmental detection of severe acute respiratory syndrome coronavirus 2 in a hospital.厕所主导医院环境中严重急性呼吸综合征冠状病毒 2 的检测。
Sci Total Environ. 2021 Jan 20;753:141710. doi: 10.1016/j.scitotenv.2020.141710. Epub 2020 Aug 15.
7
Face masks for community use: An awareness call to the differences in materials.医用口罩:呼吁社会正确使用口罩,认清材料差异。
Respirology. 2020 Aug;25(8):894-895. doi: 10.1111/resp.13891. Epub 2020 Jul 6.
8
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.SARS-CoV-2 预先存在的免疫力:已知和未知。
Nat Rev Immunol. 2020 Aug;20(8):457-458. doi: 10.1038/s41577-020-0389-z.
9
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.比较 SARS-CoV-2 与 SARS-CoV 和流感大流行。
Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3.
10
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'.Vo' 镇暴发的 SARS-CoV-2 疫情得到控制。
Nature. 2020 Aug;584(7821):425-429. doi: 10.1038/s41586-020-2488-1. Epub 2020 Jun 30.

无症状携带者和气溶胶传播严重急性呼吸综合征冠状病毒 2:主要的公共卫生挑战。

Transmission of severe acute respiratory syndrome coronavirus 2 through asymptomatic carriers and aerosols: A major public health challenge.

机构信息

Professor emérito, Faculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.

出版信息

Rev Soc Bras Med Trop. 2020 Dec 11;53:e20200669. doi: 10.1590/0037-8682-0669-2020. eCollection 2020.

DOI:10.1590/0037-8682-0669-2020
PMID:33331612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7747819/
Abstract

In the absence of vaccines and effective antiviral drugs, control of the spread of coronavirus disease (Covid-19) relies mainly on the adequacy of public health resources and policies. Hence, failure to establish and implement scientifically reliable control measures may have a significant effect on the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, severity of the disease, and death toll. The average number of secondary transmissions from an infected person, or reproduction numbers (R0 and R), and the points at which the collective immunity begins to reduce the transmission of the infection, or herd immunity thresholds, are important epidemiological tools used in strategies of Covid-19 control, suppression, and mitigation. However, SARS-CoV-2 transmission through asymptomatic carriers and, possibly, aerosols, has been ignored, and this may affect the effectiveness of Covid-19 control strategies. Therefore, consideration of the two possible ways of transmission would substantially increase the values of reproduction numbers, but if estimates of the contingent of the population naturally resistant to the virus, plus those with pre-existing cross-immunity to SARS-CoV-2 were considered, the evaluation of herd immunity thresholds should reach their real and achievable levels.

摘要

在缺乏疫苗和有效抗病毒药物的情况下,控制冠状病毒病(Covid-19)的传播主要依赖于公共卫生资源和政策的充分性。因此,如果不能建立和实施科学可靠的控制措施,可能会对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的发病率、疾病严重程度和死亡人数产生重大影响。平均每个受感染者的二次传播数量,或繁殖数(R0 和 R),以及群体免疫开始降低感染传播的临界点,或群体免疫阈值,是 Covid-19 控制、抑制和缓解策略中使用的重要流行病学工具。然而,无症状携带者的 SARS-CoV-2 传播,以及可能的气溶胶传播,一直被忽视,这可能会影响 Covid-19 控制策略的有效性。因此,如果考虑两种可能的传播方式,繁殖数的数值会大大增加,但如果考虑到对病毒自然具有抵抗力的人群,以及对 SARS-CoV-2 具有交叉免疫力的人群的数量,那么对群体免疫阈值的评估应该达到其真实和可实现的水平。